Johnson & Johnson (JNJ) Operating Expenses (2009 - 2026)

Johnson & Johnson has disclosed Operating Expenses across 18 years of filings, most recently posting $10.1 billion for Q2 2026.

• In Q2 2026, Operating Expenses rose 6.86% year-over-year to $10.1 billion; the TTM figure through Jun 2026 stood at $40.5 billion (up 0.93% YoY), while the FY2025 annual figure was $38.6 billion, down 4.38% from the prior year.
• Operating Expenses came in at $10.1 billion for Q2 2026 at Johnson & Johnson, up from $9.6 billion in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $11.8 billion in Q4 2024 to a low of $6.2 billion in Q1 2022.
• Average Operating Expenses over 5 years is $9.3 billion, with a median of $9.5 billion recorded in 2025.
• The largest YoY upside for Operating Expenses was 48.05% in 2023 against a maximum downside of 10.34% in 2023.
• Over 5 years, Operating Expenses stood at $8.5 billion in 2022, then grew by 21.36% to $10.3 billion in 2023, then climbed by 13.99% to $11.8 billion in 2024, then slipped by 5.97% to $11.1 billion in 2025, then decreased by 8.75% to $10.1 billion in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $10.1 billion in Q2 2026, $9.6 billion in Q1 2026, and $11.1 billion in Q4 2025.